MXCT vs VSBC: stock comparison and AI forecast
Maxcyte, Inc. (MXCT) and Vitaspring Biomedical Co. Ltd. (VSBC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MXCT Maxcyte, Inc.
- Price
- $1.26 +44.5% · 6M
- Market Cap
- $130M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VSBC Vitaspring Biomedical Co. Ltd.
- Market Cap
- $3M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MXCT is 40.5 times larger than VSBC by market capitalization ($130M against $3M).
- Both companies share the SEC industry classification Services-Commercial Physical & Biological Research.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MXCT | VSBC |
|---|---|---|
| Market Cap | $130M | $3M |
| P/B Ratio | 0.82x | – |
| EPS | $-0.38 | – |
| Book Value/Share | $1.54 | – |
| Revenue/Share | $0.30 | – |
| FCF/Share | $-0.23 | – |
Profitability & Margins
| Metric | MXCT | VSBC |
|---|---|---|
| ROE | -22.4% | – |
| ROA | -19.3% | -5834.5% |
| ROIC | -23.9% | -8.4% |
| Gross Margin | 79.2% | – |
| Operating Margin | -134.6% | – |
| Net Margin | -114.8% | – |
| EBT Margin | -114.8% | – |
| Tax Rate | – | -58.2% |
Financial Health
| Metric | MXCT | VSBC |
|---|---|---|
| Current Ratio | 12.26x | 0.01x |
| Quick Ratio | 11.47x | – |
| D/E Ratio | 0.16x | – |
| Financial Leverage | 1.16x | – |
| Interest Coverage | -818.0x | – |
| Working Capital | $111M | -$2M |
Cash Flow
| Metric | MXCT | VSBC |
|---|---|---|
| Operating Cash Flow | -$23M | $90K |
| Free Cash Flow | -$24M | – |
| Capital Spending | -$670K | – |
| FCF/Sales | -76.1% | – |
| CapEx/Sales | 2.1% | – |
Operational Efficiency
| Metric | MXCT | VSBC |
|---|---|---|
| Asset Turnover | 0.17x | – |
| Receivables Turnover | 7.9x | – |
| Inventory Turnover | 0.8x | – |
| Fixed Assets Turnover | 2.1x | – |
| Days Sales Outstanding | 46 days | – |
| Days Inventory | 441 days | – |
| Payables Period | 98 days | 0 days |
| Cash Conversion Cycle | 389 days | – |
Income Statement
| Metric | MXCT | VSBC |
|---|---|---|
| Total Revenue | $31M | – |
| Operating Income | -$42M | $190K |
| Net Income | -$36M | -$860K |
| R&D Expense | $17M | – |
| SG&A Expense | $47M | $590K |
| Cost of Goods Sold | $6M | $1M |
Dividend & Shareholder Information
| Metric | MXCT | VSBC |
|---|---|---|
| Shares Outstanding | 103M | 207M |
MXCT vs VSBC: stock comparison and AI forecast
Which is bigger, MXCT or VSBC?
MXCT is 40.5 times larger than VSBC by market capitalization ($130M against $3M).
Which one does Intratio's AI model rank higher, MXCT or VSBC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.